Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study.
Ladoire S, Rederstorff E, Goussot V, Parnalland S, Briot N, Ballot E, Truntzer C, Ayati S, Bengrine-Lefevre L, Bremaud N, Coudert B, Desmoulins I, Favier L, Fraisse C, Fumet JD, Hennequin A, Hervieu A, Ilie S, Kaderbhai C, Lagrange A, Martin N, Mazilu I, Mayeur D, Palmier R, Simonet-Lamm AL, Vincent J, Zanetta S, Arnould L, Coutant C, Bertaut A, Ghiringhelli F. Ladoire S, et al. Among authors: simonet lamm al. Eur J Cancer. 2022 Apr;165:13-24. doi: 10.1016/j.ejca.2022.01.005. Epub 2022 Feb 1. Eur J Cancer. 2022. PMID: 35189537 Free PMC article.
Seroprevalence of SARS-CoV-2 among the staff and patients of a French cancer centre after first lockdown: The canSEROcov study.
Ladoire S, Goussot V, Redersdorff E, Cueff A, Ballot E, Truntzer C, Ayati S, Bengrine-Lefevre L, Bremaud N, Coudert B, Desmoulins I, Favier L, Fraisse C, Fumet JD, Hanu R, Hennequin A, Hervieu A, Ilie S, Kaderbhai C, Lagrange A, Martin N, Mazilu I, Mayeur D, Palmier R, Simonet-Lamm AL, Vincent J, Zanetta S, Arnould L, Coutant C, Bertaut A, Ghiringhelli F. Ladoire S, et al. Among authors: simonet lamm al. Eur J Cancer. 2021 May;148:359-370. doi: 10.1016/j.ejca.2021.02.027. Epub 2021 Feb 27. Eur J Cancer. 2021. PMID: 33780664 Free PMC article.
Beyond QuantiFERON-TB Results, the Added Value of a Weak Mitogen Response.
Jacquier M, Binquet C, Manoha C, Audia S, Simonet-Lamm AL, Casenaz A, Sow AK, Piroth L, Blot M. Jacquier M, et al. Among authors: simonet lamm al. Front Med (Lausanne). 2022 May 30;9:876864. doi: 10.3389/fmed.2022.876864. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35712107 Free PMC article.
Informal consultation at a teaching hospital infectious diseases department.
Rameau C, Mahy S, Simonet Lamm AL, Fillion A, Buisson M, Waldner A, Duong M, Piroth L, Chavanet P. Rameau C, et al. Among authors: simonet lamm al. Med Mal Infect. 2014 Mar;44(3):107-11. doi: 10.1016/j.medmal.2014.01.009. Epub 2014 Mar 4. Med Mal Infect. 2014. PMID: 24612506
[A. meyeri spondylodiscitis].
Simonet-Lamm A, Binois R, Bador J, Chavanet P, Piroth L. Simonet-Lamm A, et al. Med Mal Infect. 2011 Nov;41(11):619-20. doi: 10.1016/j.medmal.2011.09.005. Epub 2011 Oct 20. Med Mal Infect. 2011. PMID: 22018830 French. No abstract available.